AYTU Financials
Aytu BioScience Inc - Financial statements & key metrics
Stock Price
$2.29
Market Cap
$24.15M
P/E Ratio
-1.1
EPS
$-2.23
Income Statement Highlights
Most Recent Quarter: 2025-06-30
Revenue
$66.38M
Gross Profit
-
Operating Income
-
Net Income
$-13.56M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$124.18M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$30.95M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-1.94M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-10.8%
Net Margin
-20.5%
ROE
-50.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AYTU revenue?
AYTU's most recent quarterly revenue was $66.38M. Annual revenue can be calculated by summing the four most recent quarters.
Is AYTU profitable?
AYTU reported a loss of $13.56M in the most recent quarter. The net profit margin is -20.5%.
What is AYTU market cap?
AYTU has a market capitalization of $24.15M, making it a small-cap stock.
Does AYTU have debt?
View AYTU's balance sheet for debt information.
What is AYTU cash flow?
Cash flow data is available in the full financial statements.